March 24, 2020 by Chain Drug Review
COVID-19 outbreak, Curaleaf, Joseph Lusardi
Business, Supplier News

WAKEFIELD, Mass. — Curaleaf has provided an operational update that it has received an Essential Services Designation in key markets which will allow the company to continue to meet the needs of its customers. The designation means that like pharmacies and grocery stores, Curaleaf dispensaries provide an essential service to communities and are authorized to remain
March 22, 2020 by Chain Drug Review
COVID-19 outbreak, Seniors Day, Walgreens
Leading Headlines, Retail News

DEERFIELD, Ill.— Walgreens announced on Sunday the following new services to keep seniors safe, supplied and connected during the COVID-19 pandemic: • Every Tuesday, starting Tuesday, March 24, is now Seniors Day at Walgreens with all-day discounts and seniors-only shopping from 8am-9am. This hour is also available to caregivers and immediate families. • The retailer
March 19, 2020 by Chain Drug Review
Brian Cornell, COVID-19 outbreak, Target
Leading Headlines, Retail News

MINNEAPOLIS — Target has made adjustments to its business hours and other measures amid the outbreak of the novel coronavirus (COVID-19). Beginning March 18, all Target stores will close by 9 p.m. local time daily, which will provide the team additional time for cleaning and restocking each day. In addition, the retailer announced that it
March 16, 2020 by Chain Drug Review
Bartells, COVID-19 outbreak, Kaiser Permanente Care Clinics
Leading Headlines, Retail News

SEATTLE – In light of the current need for access to essentials, Bartell’s will be adding one additional 24-hour store including pharmacy in the heaviest impacted area of Kirkland/Bellevue communities. That store is located in Bellevue Village. Bartell’s in Lower Queen Anne will remain a 24-hour store. “The intention behind this is to offer customers
March 9, 2020 by Chain Drug Review
COVID-19 outbreak, CVS Health, Dr. Troyen Brennan
Leading Headlines, Pharmacy, Retail News

WOONSOCKET, R.I. — CVS Health is taking additional steps across the company to address the COVID-19 outbreak and protect patient access to medication. “Being committed to the welfare of those we serve means being responsive to evolving needs and acting swiftly. This is particularly true in times of uncertainty,” said Dr. Troyen Brennan, executive vice president
February 18, 2020 by Chain Drug Review
COVID-19 outbreak, Dr. Paul Stoffels, Janssen Pharmaceutical Companies, Johnson & Johnson
Leading Headlines, Pharmacy, Supplier News

NEW BRUNSWICK, N.J. — Johnson & Johnson announced Tuesday that its Janssen Pharmaceutical Companies will expand its existing partnership with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health & Human Services, to seek treatment solutions for